ApprovalTrail

Approval · Notice of Compliance 7494 · 1994

RALGRO IMPLANTS: Notice of Compliance 7494

Issued November 9, 1994

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7494
Date
November 9, 1994
Company
Mallinckrodt Veterinary, Inc.Pointe-Claire, Quebec, Canada
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Growth promotant

Products in this notice

BrandDINStatus today
RALGRO IMPLANTS02137607Marketed

Medicinal ingredients